CMPS Latest Press Releases

-- September 11, 2026 --

Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360 Business Wire 4:10 PM

-- September 10, 2026 --

Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training PRNewswire 8:01 AM

Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training Business Wire 6:35 AM

Compass Pathways to Participate in Investor Conferences the Week of September 14th Business Wire 6:30 AM

-- September 9, 2026 --

Compass Pathways' New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year Business Wire 6:30 AM

-- September 8, 2026 --

Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026 Business Wire 6:30 AM

-- September 3, 2026 --

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

-- September 2, 2026 --

Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree Business Wire 6:30 AM

-- September 1, 2026 --

Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026 Business Wire 6:30 AM

-- August 6, 2026 --

Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026 Business Wire 7:00 AM

Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin Business Wire 6:30 AM

-- August 5, 2026 --

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout Globe Newswire 10:25 AM

Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights Business Wire 6:30 AM

-- July 29, 2026 --

Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026 Business Wire 6:30 AM

-- July 16, 2026 --

Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy Business Wire 6:35 AM

-- July 7, 2026 --

Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile Business Wire 6:30 AM

-- July 2, 2026 --

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:30 AM

-- June 30, 2026 --

Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity Globe Newswire 9:00 AM

-- June 29, 2026 --

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer Globe Newswire 7:30 AM

-- June 26, 2026 --

A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year PRNewswire 9:30 AM

-- June 5, 2026 --

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:30 AM

-- May 28, 2026 --

Compass Pathways Elects Kathleen Tregoning to Board of Directors Business Wire 6:30 AM

-- May 26, 2026 --

Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026 Business Wire 6:30 AM

-- May 14, 2026 --

Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026 Business Wire 6:30 AM

-- May 13, 2026 --

Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights Business Wire 6:30 AM

-- May 6, 2026 --

Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026 Business Wire 6:30 AM

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:25 AM

-- April 24, 2026 --

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher Business Wire 10:37 AM

-- April 21, 2026 --

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments Business Wire 6:30 AM

-- April 20, 2026 --

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026 Business Wire 6:30 AM

-- April 18, 2026 --

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments Business Wire 4:12 PM

-- April 14, 2026 --

Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training Business Wire 6:30 AM